Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VALEANT PHARMACEUTICALS INTL INC T.VRX

"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."


TSX:VRX - Post by User

Comment by d_trumpon Mar 17, 2016 11:13am
54 Views
Post# 24669705

RE:***** $39.91*****

RE:***** $39.91*****The big overhang is the audit.  There is obviously disagreement between VRX and their auditors, hence why they published unaudited results (and failure to produce an audit by 3/31 results in a technical default).  The auditors have huge exposure here so they are likely digging in their heals wanting further writedowns.   The downward pressure will continue until this is resolved.  Having said that, if they are able to produce the audit that is more or less in-line with the results they have released, then the stock will pop.  Until then this is a pure gamble.
<< Previous
Bullboard Posts
Next >>